Nvidia's Q1 FY2027 data center revenue hit $75.2B, up 92% due to high demand for AI chips. Broadcom's Q2 FY2026 AI chip revenue soared to $10.8B, predicting a 200% growth next quarter. Cloud giants ...

It's a refactor of QueryWise (a full-stack text-to-SQL app) into a headless tool: no web UI, no Postgres requirement. The metadata store is an embedded SQLite + sqlite-vec database, so the server runs ...

In this post, we will show you how to create email templates in the new Outlook app for Windows 11. Creating email or message templates in Microsoft Outlook (classic) involved manually composing an ...

Data centers have been on the receiving end of increasing public scrutiny, with moratoriums and local protests calling attention to water shortages, higher electricity prices, and deteriorating air ...

The vast data centers that power artificial intelligence guzzle huge amounts of energy but they also have another alarming impact, according to new research. They are creating “heat islands,” warming ...

This voice experience is generated by AI. Learn more. This voice experience is generated by AI. Learn more. Pills, tablets and capsules on world map with charts blue background. International ...

Atlas Compute has proposed a dual data center and power plant in St. Lucie County. The data center is planned to be running by 2027. Atlas Compute, however, has yet to apply for any county approvals.

Feb 26 (Reuters) - Generate Biomedicines said on Thursday that it raised $400 million in its U.S. initial public offering, pricing shares of the U.S.-based drug developer at $16 each. The offering ...

Dell shares rise around 10% Announces an additional $10 billion in share buyback Expects annual AI server revenue to grow 103% to $50 billion Reports fiscal 2027 revenue above market estimates ...

President Donald Trump said on Tuesday during his State of the Union address that his administration has told major technology companies they must build their own power plants for their data centers, ...

Generate Biomedicines Inc., a biotechnology firm using artificial intelligence in drug development, is seeking to raise as much as $425 millon in an initial public offering, as listing activity in the ...